MEDSCI HEALTHCARE HOLDINGS LIMITED Financials MedSci Healthcare Holdings Limited
Equities
2415
KYG5960J1085
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.55 HKD | +0.39% |
|
+0.39% | -46.54% |
| Apr. 26 | Certain Shares of MedSci Healthcare Holdings Limited are subject to a Lock-Up Agreement Ending on 26-APR-2024. | CI |
| Apr. 01 | Medsci Healthcare Rebounds to 2023 Profit | MT |
Valuation
| Fiscal Period: December | 2023 |
|---|---|
| Capitalization 1 | 2,346 |
| Enterprise Value (EV) 1 | 1,213 |
| P/E ratio | 53.2 x |
| Yield | - |
| Capitalization / Revenue | 6.72 x |
| EV / Revenue | 3.47 x |
| EV / EBITDA | 69.7 x |
| EV / FCF | 62,254,788 x |
| FCF Yield | 0% |
| Price to Book | 2.07 x |
| Nbr of stocks (in thousands) | 541,106 |
| Reference price 2 | 4.335 |
| Announcement Date | 4/29/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 215.9 | 297.7 | 349 | 349.2 |
| EBITDA 1 | 30.31 | 37.12 | 1.621 | 17.4 |
| EBIT 1 | 29.54 | 36.14 | 0.476 | 16.26 |
| Operating Margin | 13.69% | 12.14% | 0.14% | 4.66% |
| Earnings before Tax (EBT) 1 | 33.17 | -147.1 | -96.29 | 60.45 |
| Net income 1 | 28.91 | -151 | -99.88 | 55.04 |
| Net margin | 13.4% | -50.73% | -28.62% | 15.76% |
| EPS 2 | 3.027 | -17.64 | -12.86 | 0.0815 |
| Free Cash Flow | - | 19.17 | -25.05 | 19.48 |
| FCF margin | - | 6.44% | -7.18% | 5.58% |
| FCF Conversion (EBITDA) | - | 51.63% | - | 111.94% |
| FCF Conversion (Net income) | - | - | - | 35.39% |
| Dividend per Share | - | - | - | - |
| Announcement Date | 4/16/23 | 4/16/23 | 4/16/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | - | 9.6 | 130 | - |
| Net Cash position 1 | 269 | - | - | 1,133 |
| Leverage (Debt/EBITDA) | - | 0.2587 x | 80.26 x | - |
| Free Cash Flow | - | 19.2 | -25 | 19.5 |
| ROE (net income / shareholders' equity) | - | -233% | 95.4% | 11.3% |
| ROA (Net income/ Total Assets) | - | 4.26% | 0.04% | 1% |
| Assets 1 | - | -3,544 | -244,806 | 5,531 |
| Book Value Per Share 2 | 20.60 | -14.10 | -29.40 | 2.090 |
| Cash Flow per Share 2 | 29.00 | 69.60 | 89.90 | 0.3400 |
| Capex 1 | 1.11 | 0.89 | 0.52 | 0.18 |
| Capex / Sales | 0.51% | 0.3% | 0.15% | 0.05% |
| Announcement Date | 4/16/23 | 4/16/23 | 4/16/23 | 4/29/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -46.54% | 175M | |
| -18.17% | 3.03B | |
| -15.24% | 2.87B | |
| -36.72% | 273M | |
| +6.53% | 237M | |
| -33.52% | 113M |
- Stock Market
- Equities
- 2415 Stock
- Financials MedSci Healthcare Holdings Limited